Catalyst Pharmaceutical CPRX Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $63.73M+20.9% | $52.7M-0.2% | $52.78M+1.3% | $52.11M-8.2% | $56.74M+1.4% | ||
| $70K-2.8% | $72K0.0% | $72K-37.9% | $116K+0.9% | $115K+0.9% | ||
| $6.26M+10.6% | $5.66M-0.2% | $5.67M-25.4% | $7.6M+29.9% | $5.85M+13.1% | ||
| $59.59M+32.7% | $44.89M+38.4% | $32.44M-54.5% | $71.3M+18.7% | $60.04M-15.3% | ||
| $27K-15.6% | $32K— | $0-100% | $26K— | $0-100% | ||
| -$27K+15.6% | -$32K— | $0+100% | -$26K— | -$0+100% | ||
| $14.57M+130% | $6.33M0.0% | $6.33M0.0% | $6.33M0.0% | $6.33M— | ||
| -$12.87M+49.7% | -$25.58M-650% | $4.65M+434% | $872K-71.5% | $3.06M-31.0% | ||
| $46.69M+142% | $19.28M-48.0% | $37.09M-48.6% | $72.14M+14.3% | $63.1M-16.1% | ||
| $59.56M+32.8% | $44.86M+38.3% | $32.44M-54.5% | $71.27M+18.7% | $60.04M-15.2% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Catalyst Pharmaceutical generate?
- Catalyst Pharmaceutical (CPRX) generated $208.2M in operating cash flow over the trailing twelve months.
- What is Catalyst Pharmaceutical's free cash flow?
- After $85.0K of capital expenditures, Catalyst Pharmaceutical's free cash flow was $208.1M over the trailing twelve months, down 22.2% year over year.
- Where does Catalyst Pharmaceutical's cash flow data come from?
- Every line is extracted from Catalyst Pharmaceutical's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
